Cargando…
Hyperspectral Imaging and K-Means Classification for Histologic Evaluation of Ductal Carcinoma In Situ
Hyperspectral imaging (HSI) is a non-invasive optical imaging modality that shows the potential to aid pathologists in breast cancer diagnoses cases. In this study, breast cancer tissues from different patients were imaged by a hyperspectral system to detect spectral differences between normal and b...
Autores principales: | Khouj, Yasser, Dawson, Jeremy, Coad, James, Vona-Davis, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808285/ https://www.ncbi.nlm.nih.gov/pubmed/29468139 http://dx.doi.org/10.3389/fonc.2018.00017 |
Ejemplares similares
-
Prediction of the histologic upgrade of ductal carcinoma in situ using a combined radiomics and machine learning approach based on breast dynamic contrast-enhanced magnetic resonance imaging
por: Lee, Hyo-jae, et al.
Publicado: (2022) -
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017) -
Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
por: Wang, Yao, et al.
Publicado: (2021) -
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
por: Sagara, Yasuaki, et al.
Publicado: (2017) -
Hyperspectral Imaging as an Early Biomarker for Radiation Exposure and Microcirculatory Damage
por: Chin, Michael S., et al.
Publicado: (2015)